This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2018 Oct 23;320(16):1702-1703.

doi: 10.1001/jama.2018.13995.

Immune Checkpoint Inhibitor Toxicity in 2018

Douglas B Johnson^{1

2}, Sunandana Chandra^{3

4}, Jeffrey A Sosman^{3

4}

Affiliations

Affiliations

¹ Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
² Vanderbilt Ingram Cancer Center, Nashville, Tennessee.
³ Department of Medicine, Northwestern University Medical Center, Chicago, Illinois.
⁴ Robert H. Lurie Cancer Center, Chicago, Illinois.

PMID: 30286224
DOI: 10.1001/jama.2018.13995

Immune Checkpoint Inhibitor Toxicity in 2018

Douglas B Johnson et al. JAMA. 2018.

. 2018 Oct 23;320(16):1702-1703.

doi: 10.1001/jama.2018.13995.

Authors

Douglas B Johnson^{1

2}, Sunandana Chandra^{3

4}, Jeffrey A Sosman^{3

4}

Affiliations

¹ Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
² Vanderbilt Ingram Cancer Center, Nashville, Tennessee.
³ Department of Medicine, Northwestern University Medical Center, Chicago, Illinois.
⁴ Robert H. Lurie Cancer Center, Chicago, Illinois.

PMID: 30286224
DOI: 10.1001/jama.2018.13995

No abstract available

PubMed Disclaimer

Comment in

Adverse Events Associated With Immune Checkpoint Inhibitors.
Jhaveri KD, Wanchoo R. Jhaveri KD, et al. JAMA. 2019 Mar 26;321(12):1218-1219. doi: 10.1001/jama.2018.22114. JAMA. 2019. PMID: 30912827 No abstract available.
Adverse Events Associated With Immune Checkpoint Inhibitors.
Akturk HK, Michels AW. Akturk HK, et al. JAMA. 2019 Mar 26;321(12):1219. doi: 10.1001/jama.2018.22119. JAMA. 2019. PMID: 30912828 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems